Adverse Events of Cabozantinib as a Potential Prognostic Factor in Metastatic Renal Cell Carcinoma Patients: Real-World Experience in a Single-Center Retrospective Study by Piotr Domański, Mateusz Piętak, Barbara Kruczyk, Jadwiga Jarosińska, Anna Mydlak, Tomasz Demkow, Marta Darewicz, Bożena Sikora-Kupis, Paulina Dumnicka, Wojciech Kamzol, Jakub Kucharz

Subjects: Get full text

The value of the multidisciplinary team in metastatic renal cell carcinoma: Paving the way for precision medicine in toxicities management by Michela Roberto, Martina Panebianco, Anna Maria Aschelter, Dorelsa Buccilli, Carmen Cantisani, Salvatore Caponnetto, Enrico Cortesi, Sara d’Amuri, Claudia Fofi, Debora Ierinò, Viviana Maestrini, Paolo Marchetti, Massimo Marignani, Antonio Stigliano, Luca Vivona, Daniele Santini, Silverio Tomao

Subjects: Get full text

Impact of Tyrosine Kinase Inhibitors (TKIs) Combined With Radiation Therapy for the Management of Brain Metastases From Renal Cell Carcinoma by Muhammad Khan, Muhammad Khan, Zhihong Zhao, Sumbal Arooj, Guixiang Liao

Subjects: Get full text

Immunotherapy in advanced kidney cancer: an alternative meta-analytic method using reconstructed survival data in case of proportional hazard assumption violation by Luigi Nocera, Giuseppe Fallara, Daniele Raggi, Federico Belladelli, Daniele Robesti, Francesco Montorsi, Pierre I. Karakiewicz, Bernard Malavaud, Guillaume Ploussard, Guillaume Ploussard, Andrea Necchi, Alberto Martini, Alberto Martini

Subjects: “…metastatic renal cell carcinoma (mRCC)…”
Get full text